Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Haemonetics (HAE) over the last 16 years, with Q4 2025 value amounting to $216.1 million.

  • Haemonetics' Other Non-Current Assets rose 3471.02% to $216.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $216.1 million, marking a year-over-year increase of 3471.02%. This contributed to the annual value of $164.1 million for FY2025, which is 2032.29% up from last year.
  • Haemonetics' Other Non-Current Assets amounted to $216.1 million in Q4 2025, which was up 3471.02% from $208.0 million recorded in Q3 2025.
  • In the past 5 years, Haemonetics' Other Non-Current Assets registered a high of $216.1 million during Q4 2025, and its lowest value of $63.2 million during Q2 2022.
  • In the last 5 years, Haemonetics' Other Non-Current Assets had a median value of $117.2 million in 2023 and averaged $121.8 million.
  • As far as peak fluctuations go, Haemonetics' Other Non-Current Assets crashed by 1083.07% in 2022, and later surged by 6925.09% in 2023.
  • Quarter analysis of 5 years shows Haemonetics' Other Non-Current Assets stood at $66.6 million in 2021, then skyrocketed by 55.08% to $103.3 million in 2022, then grew by 23.39% to $127.4 million in 2023, then increased by 25.87% to $160.4 million in 2024, then soared by 34.71% to $216.1 million in 2025.
  • Its Other Non-Current Assets stands at $216.1 million for Q4 2025, versus $208.0 million for Q3 2025 and $196.3 million for Q2 2025.